Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 14, 2019

BUY
$38.66 - $47.41 $108,247 - $132,748
2,800 Added 49.12%
8,500 $389,000
Q1 2019

May 15, 2019

SELL
$41.26 - $58.35 $4,126 - $5,835
-100 Reduced 1.72%
5,700 $248,000
Q4 2018

Feb 14, 2019

BUY
$44.93 - $73.38 $17,972 - $29,352
400 Added 7.41%
5,800 $274,000
Q3 2018

Nov 14, 2018

SELL
$56.85 - $80.35 $631,035 - $891,884
-11,100 Reduced 67.27%
5,400 $403,000
Q2 2018

Aug 14, 2018

BUY
$35.85 - $57.05 $107,550 - $171,150
3,000 Added 22.22%
16,500 $911,000
Q1 2018

May 15, 2018

BUY
$27.0 - $38.5 $153,900 - $219,450
5,700 Added 73.08%
13,500 $514,000
Q4 2017

Feb 14, 2018

SELL
$28.0 - $33.2 $61,600 - $73,040
-2,200 Reduced 22.0%
7,800 $218,000
Q3 2017

Nov 14, 2017

BUY
$24.5 - $31.1 $245,000 - $311,000
10,000
10,000 $310,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $539M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.